These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6987786

  • 1. Interaction of cyclosporin A with antilymphocyte serum and with enhancing serum for the suppression of renal allograft rejection in the rat.
    Homan WP, Fabre JW, Millard PR, Morris PJ.
    Transplantation; 1980 Mar; 29(3):219-22. PubMed ID: 6987786
    [Abstract] [Full Text] [Related]

  • 2. Effect of cyclosporin A upon second-set rejection of rat renal allografts.
    Homan WP, Fabre JW, Millard PR, Morris PJ.
    Transplantation; 1980 Nov; 30(5):354-7. PubMed ID: 7006168
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the effects of cyclosporin A upon renal allograft rejection in the dog.
    Homan WP, French ME, Millard P, Denton TG, Fabre JW, Morris PJ.
    Surgery; 1980 Jul; 88(1):168-73. PubMed ID: 6992318
    [Abstract] [Full Text] [Related]

  • 9. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA, Chambers WH, Monaco AP, Maki T.
    Transplantation; 1998 Mar 15; 65(5):727-34. PubMed ID: 9521210
    [Abstract] [Full Text] [Related]

  • 10. Studies on the specific suppression of renal allograft rejection in presensitised rats. Theoretical and clinical implications.
    Fabre JW, Morris PJ.
    Transplantation; 1975 Feb 15; 19(2):121-33. PubMed ID: 1091037
    [Abstract] [Full Text] [Related]

  • 11. Use of cyclophosphamide and enhancing serum to suppress renal allograft rejection in the rat.
    Winearls CG, Fabre JW, Millard PR, Morris PJ.
    Transplantation; 1979 Oct 15; 28(4):271-4. PubMed ID: 388758
    [Abstract] [Full Text] [Related]

  • 12. Islet transplantation--synergism between antilymphocyte and antimacrophage agents.
    Nash JR, Bell PR.
    J Surg Res; 1984 Feb 15; 36(2):154-7. PubMed ID: 6319820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA, Gottschalk R, Maki T, Monaco AP.
    Transplantation; 1998 Feb 27; 65(4):473-9. PubMed ID: 9500619
    [Abstract] [Full Text] [Related]

  • 17. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt.
    Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW.
    Surgery; 1976 Apr 27; 79(4):384-92. PubMed ID: 769219
    [Abstract] [Full Text] [Related]

  • 18. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ.
    Immunol Rev; 1980 Apr 27; 49():93-125. PubMed ID: 6445324
    [No Abstract] [Full Text] [Related]

  • 19. Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy.
    Schulak JA, Drevyanko TF.
    Surgery; 1985 Aug 27; 98(2):330-7. PubMed ID: 3895543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.